ClinicalTrials.Veeva

Menu

Determination of the Optimal Nutrient Mix to Acutely Increase Plasma Ketones

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Completed

Conditions

Overweight and Obesity

Treatments

Dietary Supplement: non-ketogenic control
Dietary Supplement: 25g MCT-based nutrient mix + cofactors
Dietary Supplement: 25g MCT-based nutrient mix

Study type

Interventional

Funder types

Other

Identifiers

NCT06511206
NL86023.068.23

Details and patient eligibility

About

This study will be performed to determine the optimal nutrient mix (predominantly based on medium-chain triglycerides (MCTs)) to induce a mild ketogenic state in healthy older (60-80y), overweight/obese (BMI: 25-35 kg/m2) individuals. Since the aim is to induce a mild ketogenic state, a 25g MCT-based nutrient mix, a 25g MCT-based nutrient mix + cofactors, or a non-ketogenic control will be compared.

Enrollment

11 patients

Sex

All

Ages

60 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 60-80 years
  • Body mass index (BMI) 25-35 kg/m2
  • Stable dietary habits (no weight loss or gain > 5 kg in the past 3 months)
  • Participants are able to provide signed and dated written informed consent prior to any study specific procedures

Exclusion criteria

  • Type 2 diabetes

  • Pre-diabetes based on one or a combination of the following criteria:

    • ImpairedFastingGlucose(IFG):Fasting plasma glucose ≥ 6.1mmol/l and ≤ 6.9 mmol/l.
    • HbA1c of 5.7-6.4%.
  • Participants with active congestive heart failure and/or severe renal and or liver insufficiency

  • Uncontrolled hypertension

  • Alcohol consumption of > 3 servings per day for man and > 2 servings per day for woman

  • Unstable body weight (weight gain or loss > 5 kg in the last 3 months)

  • Previous enrolment in a clinical study with an investigational product during the last 3 months or as judged by the investigator which would possibly hamper our study results

  • Significant food allergies/intolerance (seriously hampering study meals)

  • Participants who do not want to be informed about unexpected medical findings

  • Blood donation during or within 2 months prior to the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

11 participants in 3 patient groups, including a placebo group

25g MCT-based nutrient mix
Experimental group
Treatment:
Dietary Supplement: 25g MCT-based nutrient mix
25g MCT-based nutrient mix + cofactors
Experimental group
Treatment:
Dietary Supplement: 25g MCT-based nutrient mix + cofactors
non-ketogenic control
Placebo Comparator group
Treatment:
Dietary Supplement: non-ketogenic control

Trial contacts and locations

1

Loading...

Central trial contact

Merel Timmermans, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems